| Catalog_no |
ADMC0052 |
| Product_name |
I-BET151 (GSK1210151A) |
| Category |
抑制剂与激动剂 |
| Size |
10mg/50mg/100mg |
| Price |
1340.00/4000.00/7000.00 |
| Specificity |
Target: Epigenetic Reader Domain. Fields: I-BET151 (GSK1210151A) is a novel selective BET inhibitor for BRD2, BRD3 and BRD4 with IC50 of 0.5 μM, 0.25 μM, and 0.79 μM, respectively. |
| Dilution |
pIC50: 6.1 (BRD4), 6.3 (BRD2), 6.6 (BRD3)[1] |
| Purification |
>98% |
| Concentration |
靶点：Epigenetic Reader Domain;IC50：p 6.1 (BRD4), 6.3 (BRD2), 6.6 (BRD3)[1] |
| Storage_stability |
2 years -20°C Powder, 2 weeks4°C in DMSO,6 months-80°C in DMSO |
| othername |
GSK-1210151A，IBET151，I-BET-151，I BET 151，IBET-151，IBET 151,GSK 1210151A |
| Molecular Weight |
415.44 |
| Notes |
I-BET151 (GSK1210151A) is a novel selective BET inhibitor for BRD2, BRD3 and BRD4 with IC50 of 0.5 μM, 0.25 μM, and 0.79 μM, respectively. |
| Instructions |
 查看与下载 |
